INS and Other metabolic disease: As expected, subjects with each components of metabolic disorders had an adverse metabolic profile, including significantly higher levels of BMI, waist circumference, visceral fat level, systolic and diastolic BP, fasting plasma glucose and insulin, postprandial glucose and insulin, triglyceride, total cholesterol, and HOMA-IR, and lower levels of HDL-c and MVF ratio.